NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

CRO (醫藥品開發業務受託)的全球市場 (2021-2027年):市場預測 (各服務類型、治療領域、終端用戶)、產業趨勢、地區的展望、用途的潛在性、價格趨勢、市場佔有率

Contract Research Organization Market Size By Service Type, By Therapeutic Area, By End-use, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027

出版商 Global Market Insights Inc. 商品編碼 1001593
出版日期 內容資訊 英文 253 Pages
商品交期: 2-3個工作天內
價格
CRO (醫藥品開發業務受託)的全球市場 (2021-2027年):市場預測 (各服務類型、治療領域、終端用戶)、產業趨勢、地區的展望、用途的潛在性、價格趨勢、市場佔有率 Contract Research Organization Market Size By Service Type, By Therapeutic Area, By End-use, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027
出版日期: 2021年04月20日內容資訊: 英文 253 Pages
簡介

CRO (醫藥品開發業務受託)的市場在預測期間內預計顯示大幅度的成長。

癌症及心血管疾病的發病率增加,許多臨床試驗的實施情形等促進該市場的成長。

各服務種類,法律規章諮詢服務的部門2020年表現55億美元的規模,在預測期間內也顯示強勢成長。各治療領域中,心臟病的部門預計至2027年終表現26億美元以上的規模。臨床試驗的數量增加和心血管疾病的盛行率上升帶動該部門的成長。

本報告提供全球CRO (醫藥品開發業務受託)的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,法律制度,市場規模的變化、預測,服務類型、治療領域、終端用戶、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

第1章 調查手法、調查範圍

第2章 摘要整理

第3章 產業分析

  • 產業的分類
  • 產業形勢
  • 對產業的影響要素
    • 成長要素
    • 潛在的風險&課題
  • 成長可能性
  • COVID-19:影響分析
  • 法規情形
  • 波特分析
  • 競爭情形
  • PESTEL分析

第4章 市場分析、預測:各服務形式

  • 初期階段的開發服務
    • 發現階段
    • 化學、製造、管理(CMC)
    • 前臨床服務
  • 臨床研究服務
    • 階段I
    • 階段II
    • 階段III
    • 階段IV
  • 化驗服務
    • 生物分析實驗服務
    • 分析實驗服務
  • 法律規章諮詢服務

第5章 市場分析、預測:各治療領域

  • 腫瘤
  • 臨床藥理
  • 心臟病
  • 感染疾病
  • 神經
  • 消化器官、肝臟
  • 眼科
  • 其他

第6章 市場分析、預測:各終端用戶

  • 製藥、生物醫藥品企業
  • 醫療設備企業
  • 學術機構

第7章 市場分析、預測:各地區、主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東
  • 非洲

第8章 企業簡介

  • 競爭儀表板
  • Charles River Laboratories
  • Clinicpace
  • CMIC Holding Co.,LTD
  • EPS International Co., Ltd
  • ICON plc
  • IQVIA
  • Laboratory Corporation of American Holding (Covance Inc)
  • Medpace, Inc
  • Parexel International Corporation
  • Pharmaceutical Product Development, LLC (PPD)
  • PRA Health Sciences
  • Syneos Health
  • Synteract
  • Worldwide Clinical Trials
  • WuXi AppTec
目錄
Product Code: 3012

Title:
Contract Research Organization (CRO) Market Size By Service Type (Early Phase Development Services {Discovery Services, Chemistry, Manufacturing & Control (CMC), Pre-clinical Services [Pharmacokinetics/Pharmacodynamics (PK/PD), Toxicology Testing Services]}, Clinical Research Services {Phase I, Phase II, Phase III, Phase IV}, Laboratory Services {Bioanalytical Testing Services, Analytical Testing Services [Physical Characterization, Raw Material Testing, Batch Release Testing, Stability Testing]}, Consulting Services), By Therapeutic Area (Oncology, Clinical Pharmacology, Cardiology, Infectious Disease, Neurology, Gastroenterology & Hepatology, Ophthalmology), By End-use (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Academic Institutes), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027.

The contract research organization market is projected to foresee commendable growth by 2027 owing to rising prevalence of cancer, increasing incidence of cardiovascular disorders, and the numerous clinical trials being conducted globally. A CRO or contract research organization, is an organization hired by a firm in the medical domain to essentially manage the its clinical trials and also conduct other related tasks so as to bring a device new or drug into the market.

While CROs mainly make contracts with companies that are active in the medical device, biotechnology, and pharmaceutical field, their customers also include universities, foundations, and governmental institutions.

Contract research organization's play an essential role in all facets of the medical device or drug development process, right from early discovery to launch, focusing mainly on Phase I to III clinical trials.

The contract research organization market is bifurcated in terms of service type, therapeutic area, end-use and regional landscape.

Based on service type, the CRO market is classified into regulatory consulting services, laboratory services, clinical research services, and early phase development services. Among these, the regulatory consulting services segment accounted for $5.5 billion in 2020 and is anticipated to showcase a decent growth rate during the study period.

With respect to therapeutic area, the market for contract research organization is categorized into ophthalmology, gastroenterology & hepatology, neurology, infectious disease, cardiology, clinical pharmacology, oncology, and others. Among these, the cardiology segment is expected to reach a valuation of more than $2.6 billion by the end of 2027.

Increasing number of clinical trials and the rising prevalence of cardiovascular diseases across the globe would support the segmental growth during the forecast period.

In terms of end-use, the overall contract research organization is segmented into academic institutes, medical device companies, and pharmaceutical and biopharmaceutical companies. In 2020, the segment for pharmaceutical & biopharmaceutical enterprises accounted for a 55.2% market share. Industry outlooks are expecting the segment to see substantial growth over the coming time period.

On the regional front, in 2020, the contract research organization market in Latin America held a market share of 4.5% and anticipated to register similar growth patterns in the times to come.

Meanwhile, Middle East & Africa CRO market is expected to showcase steady growth of 6.8% during the analysis period. Increasing prevalence of cancer in Gulf countries, rising number of contract research organizations, and surging number of clinical trials will aid the regional market growth.

In fact, UAE is now becoming one of the prominent regional hubs for clinical trials, presenting more and more in Dubai regional as well as scientific offices of pharma companies and CROs offices.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definitions
  • 1.2 Base estimates & working
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data Sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Contract research organization industry 360 degree synopsis, 2016 - 2027
    • 2.1.1 Business trends
    • 2.1.2 Service type trends
    • 2.1.3 Therapeutic area trends
    • 2.1.4 End-use trends
    • 2.1.5 Regional trends

Chapter 3 Contract Research Organization Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2016 - 2027
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing R&D expenditure worldwide
      • 3.3.1.2 Growing number of clinical trials in emerging countries
      • 3.3.1.3 Growing outsourcing of R&D activities
      • 3.3.1.4 Rising technological advancements
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Intellectual property rights issues
      • 3.3.2.2 Stringent regulatory policies
  • 3.4 Growth potential analysis
    • 3.4.1 By service type
    • 3.4.2 By therapeutic area
    • 3.4.3 By end-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Regulatory landscape
  • 3.7 Porter's analysis
  • 3.8 Competitive landscape, 2020
    • 3.8.1 Company matrix analysis
  • 3.9 PESTEL analysis

Chapter 4 Contract Research Organization Market, By Service Type

  • 4.1 Key segment trend
  • 4.2 Early phase development services
    • 4.2.1 Market size, by region, 2016 - 2027 (USD Million)
    • 4.2.2 Discovery phase
      • 4.2.2.1 Market size, by region, 2016 - 2027 (USD Million)
    • 4.2.3 Chemistry, manufacturing & control (CMC)
      • 4.2.3.1 Market size, by region, 2016 - 2027 (USD Million)
    • 4.2.4 Preclinical services
      • 4.2.4.1 Market size, by region, 2016 - 2027 (USD Million)
      • 4.2.4.2 Pharmacokinetic/Pharmacodynamic (PK/PD)
        • 4.2.4.2.1 Market size, by region, 2016 - 2027 (USD Million)
      • 4.2.4.3 Toxicology testing services
        • 4.2.4.3.1 Market size, by region, 2016 - 2027 (USD Million)
      • 4.2.4.4 Others
        • 4.2.4.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.3 Clinical research services
    • 4.3.1 Market size, by region, 2016 - 2027 (USD Million)
    • 4.3.2 Phase I
      • 4.3.2.1 Market size, by region, 2016 - 2027 (USD Million)
    • 4.3.3 Phase II
      • 4.3.3.1 Market size, by region, 2016 - 2027 (USD Million)
    • 4.3.4 Phase III
      • 4.3.4.1 Market size, by region, 2016 - 2027 (USD Million)
    • 4.3.5 Phase IV
      • 4.3.5.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.4 Laboratory services
    • 4.4.1 Market size, by region, 2016 - 2027 (USD Million)
    • 4.4.2 Bioanalytical testing services
      • 4.4.2.1 Market size, by region, 2016 - 2027 (USD Million)
    • 4.4.3 Analytical testing services
      • 4.4.3.1 Market size, by region, 2016 - 2027 (USD Million)
      • 4.4.3.2 Physical characterization
        • 4.4.3.2.1 Market size, by region, 2016 - 2027 (USD Million)
      • 4.4.3.3 Raw material testing
        • 4.4.3.3.1 Market size, by region, 2016 - 2027 (USD Million)
      • 4.4.3.4 Stability testing
        • 4.4.3.4.1 Market size, by region, 2016 - 2027 (USD Million)
      • 4.4.3.5 Others
        • 4.4.3.5.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.5 Regulatory consulting services
    • 4.5.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 5 Contract Research Organization Market, By Therapeutic Area

  • 5.1 Key segment trend
  • 5.2 Oncology
    • 5.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.3 Clinical pharmacology
    • 5.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.4 Cardiology
    • 5.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.5 Infectious disease
    • 5.5.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.6 Neurology
    • 5.6.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.7 Gastroenterology & hepatology
    • 5.7.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.8 Ophthalmology
    • 5.8.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.9 Others
    • 5.9.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 6 Contract Research Organization Market, By End-use

  • 6.1 Key segment trend
  • 6.2 Pharmaceutical & biopharmaceutical companies
    • 6.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.3 Medical device companies
    • 6.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.4 Academic institutes
    • 6.4.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 7 Contract Research Organization Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country, 2016 - 2027 (USD Million)
    • 7.2.2 Market size, by service type, 2016 - 2027 (USD Million)
      • 7.2.2.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
        • 7.2.2.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
      • 7.2.2.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
      • 7.2.2.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
        • 7.2.2.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
    • 7.2.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.2.4 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.2.5 U.S.
      • 7.2.5.1 Market size, by service type, 2016 - 2027 (USD Million)
        • 7.2.5.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
        • 7.2.5.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
        • 7.2.5.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
        • 7.2.5.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
        • 7.2.5.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
      • 7.2.5.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.2.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.2.6 Canada
      • 7.2.6.1 Market size, by service type, 2016 - 2027 (USD Million)
        • 7.2.6.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
        • 7.2.6.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
        • 7.2.6.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
        • 7.2.6.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
        • 7.2.6.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
      • 7.2.6.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.2.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.3 Europe
    • 7.3.1 Market size, by country, 2016 - 2027 (USD Million)
    • 7.3.2 Market size, by service type, 2016 - 2027 (USD Million)
      • 7.3.2.1 Market size, by early phase development, 2016 - 2027 (USD Million)
        • 7.3.2.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
      • 7.3.2.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
      • 7.3.2.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
        • 7.3.2.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
    • 7.3.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.3.4 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.3.5 Germany
      • 7.3.5.1 Market size, by service type, 2016 - 2027 (USD Million)
        • 7.3.5.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
        • 7.3.5.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
        • 7.3.5.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
        • 7.3.5.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
        • 7.3.5.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
      • 7.3.5.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.3.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.3.6 UK
      • 7.3.6.1 Market size, by service type, 2016 - 2027 (USD Million)
        • 7.3.6.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
        • 7.3.6.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
        • 7.3.6.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
        • 7.3.6.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
        • 7.3.6.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
      • 7.3.6.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.3.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.3.7 France
      • 7.3.7.1 Market size, by service type, 2016 - 2027 (USD Million)
        • 7.3.7.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
        • 7.3.7.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
        • 7.3.7.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
        • 7.3.7.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
        • 7.3.7.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
      • 7.3.7.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.3.7.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.3.8 Spain
      • 7.3.8.1 Market size, by service type, 2016 - 2027 (USD Million)
        • 7.3.8.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
        • 7.3.8.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
        • 7.3.8.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
        • 7.3.8.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
        • 7.3.8.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
      • 7.3.8.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.3.8.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.3.9 Italy
      • 7.3.9.1 Market size, by service type, 2016 - 2027 (USD Million)
        • 7.3.9.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
        • 7.3.9.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
        • 7.3.9.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
        • 7.3.9.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
        • 7.3.9.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
      • 7.3.9.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.3.9.3 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country, 2016 - 2027 (USD Million)
    • 7.4.2 Market size, by service type, 2016 - 2027 (USD Million)
      • 7.4.2.1 Market size, by early phase development, 2016 - 2027 (USD Million)
        • 7.4.2.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
      • 7.4.2.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
      • 7.4.2.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
        • 7.4.2.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
    • 7.4.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.4.4 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.4.5 China
      • 7.4.5.1 Market size, by service type, 2016 - 2027 (USD Million)
        • 7.4.5.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
        • 7.4.5.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
        • 7.4.5.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
        • 7.4.5.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
        • 7.4.5.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
      • 7.4.5.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.4.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.4.6 Japan
      • 7.4.6.1 Market size, by service type, 2016 - 2027 (USD Million)
        • 7.4.6.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
        • 7.4.6.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
        • 7.4.6.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
        • 7.4.6.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
        • 7.4.6.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
      • 7.4.6.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.4.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.4.7 India
      • 7.4.7.1 Market size, by service type, 2016 - 2027 (USD Million)
        • 7.4.7.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
        • 7.4.7.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
        • 7.4.7.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
        • 7.4.7.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
        • 7.4.7.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
      • 7.4.7.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.4.7.3 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Market size, by country, 2016 - 2027 (USD Million)
    • 7.5.2 Market size, by service type, 2016 - 2027 (USD Million)
      • 7.5.2.1 Market size, by early phase development, 2016 - 2027 (USD Million)
        • 7.5.2.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
      • 7.5.2.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
      • 7.5.2.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
        • 7.5.2.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
    • 7.5.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.5.4 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.5.5 Brazil
      • 7.5.5.1 Market size, by service type, 2016 - 2027 (USD Million)
        • 7.5.5.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
        • 7.5.5.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
        • 7.5.5.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
        • 7.5.5.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
        • 7.5.5.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
      • 7.5.5.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.5.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.5.6 Mexico
      • 7.5.6.1 Market size, by service type, 2016 - 2027 (USD Million)
        • 7.5.6.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
        • 7.5.6.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
        • 7.5.6.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
        • 7.5.6.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
        • 7.5.6.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
      • 7.5.6.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.5.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.6 Middle East and Africa
    • 7.6.1 Market size, by country, 2016 - 2027 (USD Million)
    • 7.6.2 Market size, by service type, 2016 - 2027 (USD Million)
      • 7.6.2.1 Market size, by early phase development, 2016 - 2027 (USD Million)
        • 7.6.2.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
      • 7.6.2.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
      • 7.6.2.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
        • 7.6.2.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
    • 7.6.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.6.4 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.6.5 South Africa
      • 7.6.5.1 Market size, by service type, 2016 - 2027 (USD Million)
        • 7.6.5.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
        • 7.6.5.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
        • 7.6.5.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
        • 7.6.5.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
        • 7.6.5.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
      • 7.6.5.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.6.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.6.6 Saudi Arabia
      • 7.6.6.1 Market size, by service type, 2016 - 2027 (USD Million)
        • 7.6.6.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
        • 7.6.6.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
        • 7.6.6.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
        • 7.6.6.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
        • 7.6.6.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
      • 7.6.6.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
      • 7.6.6.3 Market size, by end-use, 2016 - 2027 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Competitive dashboard, 2020
  • 8.2 Charles River Laboratories
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Product landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 SWOT analysis
  • 8.3 Clinicpace
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Product landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 SWOT analysis
  • 8.4 CMIC Holding Co.,LTD
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Product landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 SWOT analysis
  • 8.5 EPS International Co., Ltd
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Product landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 SWOT analysis
  • 8.6 ICON plc
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Product landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 SWOT analysis
  • 8.7 IQVIA
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Product landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 SWOT analysis
  • 8.8 Laboratory Corporation of American Holding (Covance Inc)
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Product landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 SWOT analysis
  • 8.9 Medpace, Inc
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Product landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 SWOT analysis
  • 8.10 Parexel International Corporation
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Product landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 SWOT analysis
  • 8.11 Pharmaceutical Product Development, LLC (PPD)
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Product landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 SWOT analysis
  • 8.12 PRA Health Sciences
    • 8.12.1 Business overview
    • 8.12.2 Financial data
    • 8.12.3 Product landscape
    • 8.12.4 Strategic outlook
    • 8.12.5 SWOT analysis
  • 8.13 Syneos Health
    • 8.13.1 Business overview
    • 8.13.2 Financial data
    • 8.13.3 Product landscape
    • 8.13.4 Strategic outlook
    • 8.13.5 SWOT analysis
  • 8.14 Synteract
    • 8.14.1 Business overview
    • 8.14.2 Financial data
    • 8.14.3 Product landscape
    • 8.14.4 Strategic outlook
    • 8.14.5 SWOT analysis
  • 8.15 Worldwide Clinical Trials
    • 8.15.1 Business overview
    • 8.15.2 Financial data
    • 8.15.3 Product landscape
    • 8.15.4 Strategic outlook
    • 8.15.5 SWOT analysis
  • 8.16 WuXi AppTec
    • 8.16.1 Business overview
    • 8.16.2 Financial data
    • 8.16.3 Product landscape
    • 8.16.4 Strategic outlook
    • 8.16.5 SWOT analysis

Data Tables

  • TABLE 1 CRO industry 360 degree synopsis, 2016 - 2027
  • TABLE 2 CRO market, 2016 - 2020 (USD Million)
  • TABLE 3 CRO market, 2021 - 2027 (USD Million)
  • TABLE 4 CRO market, by service type, 2016 - 2020 (USD Million)
  • TABLE 5 CRO market, by service type, 2021 - 2027 (USD Million)
  • TABLE 6 CRO market, by therapeutic area, 2016 - 2020 (USD Million)
  • TABLE 7 CRO market, by therapeutic area, 2021 - 2027 (USD Million)
  • TABLE 8 CRO market, by end-use, 2016 - 2020 (USD Million)
  • TABLE 9 CRO market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 10 CRO market, by region, 2016 - 2020 (USD Million)
  • TABLE 11 CRO market, by region, 2021 - 2027 (USD Million)
  • TABLE 12 Industry impact forces
  • TABLE 13 Early phase development services market size, by region, 2016 - 2020 (USD Million)
  • TABLE 14 Early phase development services market size, by region, 2021 - 2027 (USD Million)
  • TABLE 15 Discovery services market size, by region, 2016 - 2020 (USD Million)
  • TABLE 16 Discovery services market size, by region, 2021 - 2027 (USD Million)
  • TABLE 17 CMC market size, by region, 2016 - 2020 (USD Million)
  • TABLE 18 CMC market size, by region, 2021 - 2027 (USD Million)
  • TABLE 19 Pre-clinical services market size, by region, 2016 - 2020 (USD Million)
  • TABLE 20 Pre-clinical services market size, by region, 2021 - 2027 (USD Million)
  • TABLE 21 PK/PD market size, by region, 2016 - 2020 (USD Million)
  • TABLE 22 PK/PD market size, by region, 2021 - 2027 (USD Million)
  • TABLE 23 Toxicology testing services market size, by region, 2016 - 2020 (USD Million)
  • TABLE 24 Toxicology testing services market size, by region, 2021 - 2027 (USD Million)
  • TABLE 25 Others market size, by region, 2016 - 2020 (USD Million)
  • TABLE 26 Others market size, by region, 2021 - 2027 (USD Million)
  • TABLE 27 Clinical research services market size, by region, 2016 - 2020 (USD Million)
  • TABLE 28 Clinical research services market size, by region, 2021 - 2027 (USD Million)
  • TABLE 29 Phase I market size, by region, 2016 - 2020 (USD Million)
  • TABLE 30 Phase I market size, by region, 2021 - 2027 (USD Million)
  • TABLE 31 Phase II market size, by region, 2016 - 2020 (USD Million)
  • TABLE 32 Phase II market size, by region, 2021 - 2027 (USD Million)
  • TABLE 33 Phase III market size, by region, 2016 - 2020 (USD Million)
  • TABLE 34 Phase III market size, by region, 2021 - 2027 (USD Million)
  • TABLE 35 Phase IV market size, by region, 2016 - 2020 (USD Million)
  • TABLE 36 Phase IV market size, by region, 2021 - 2027 (USD Million)
  • TABLE 37 Laboratory services market size, by region, 2016 - 2020 (USD Million)
  • TABLE 38 Laboratory services market size, by region, 2021 - 2027 (USD Million)
  • TABLE 39 Bioanalytical testing services market size, by region, 2016 - 2020 (USD Million)
  • TABLE 40 Bioanalytical testing services market size, by region, 2021 - 2027 (USD Million)
  • TABLE 41 Analytical testing services market size, by region, 2016 - 2020 (USD Million)
  • TABLE 42 Analytical testing services market size, by region, 2021 - 2027 (USD Million)
  • TABLE 43 Physical characterization market size, by region, 2016 - 2020 (USD Million)
  • TABLE 44 Physical characterization market size, by region, 2021 - 2027 (USD Million)
  • TABLE 45 Raw material testing market size, by region, 2016 - 2020 (USD Million)
  • TABLE 46 Raw material testing market size, by region, 2021 - 2027 (USD Million)
  • TABLE 47 Batch release testing market size, by region, 2016 - 2020 (USD Million)
  • TABLE 48 Batch release testing market size, by region, 2021 - 2027 (USD Million)
  • TABLE 49 Stability testing market size, by region, 2016 - 2020 (USD Million)
  • TABLE 50 Stability testing market size, by region, 2021 - 2027 (USD Million)
  • TABLE 51 Others market size, by region, 2016 - 2020 (USD Million)
  • TABLE 52 Others market size, by region, 2021 - 2027 (USD Million)
  • TABLE 53 Consulting services market size, by region, 2016 - 2020 (USD Million)
  • TABLE 54 Consulting services market size, by region, 2021 - 2027 (USD Million)
  • TABLE 55 Oncology market size, by region, 2016 - 2020 (USD Million)
  • TABLE 56 Oncology market size, by region, 2021 - 2027 (USD Million)
  • TABLE 57 Clinical pharmacology market size, by region, 2016 - 2020 (USD Million)
  • TABLE 58 Clinical pharmacology market size, by region, 2021 - 2027 (USD Million)
  • TABLE 59 Cardiology market size, by region, 2016 - 2020 (USD Million)
  • TABLE 60 Cardiology market size, by region, 2021 - 2027 (USD Million)
  • TABLE 61 Infectious disease market size, by region, 2016 - 2020 (USD Million)
  • TABLE 62 Infectious disease market size, by region, 2021 - 2027 (USD Million)
  • TABLE 63 Neurology market size, by region, 2016 - 2020 (USD Million)
  • TABLE 64 Neurology market size, by region, 2021 - 2027 (USD Million)
  • TABLE 65 Gastroenterology & hepatology market size, by region, 2016 - 2020 (USD Million)
  • TABLE 66 Gastroenterology & hepatology market size, by region, 2021 - 2027 (USD Million)
  • TABLE 67 Ophthalmology market size, by region, 2016 - 2020 (USD Million)
  • TABLE 68 Ophthalmology market size, by region, 2021 - 2027 (USD Million)
  • TABLE 69 Others market size, by region, 2016 - 2020 (USD Million)
  • TABLE 70 Others market size, by region, 2021 - 2027 (USD Million)
  • TABLE 71 Pharmaceutical & biopharmaceutical companies market size, by region, 2016 - 2020 (USD Million)
  • TABLE 72 Pharmaceutical & biopharmaceutical companies market size, by region, 2021 - 2027 (USD Million)
  • TABLE 73 Medical device companies market size, by region, 2016 - 2020 (USD Million)
  • TABLE 74 Medical device companies market size, by region, 2021 - 2027 (USD Million)
  • TABLE 75 Academic institutes market size, by region, 2016 - 2020 (USD Million)
  • TABLE 76 Academic institutes market size, by region, 2021 - 2027 (USD Million)
  • TABLE 77 North America CRO market size, by country, 2016 - 2020 (USD Mn)
  • TABLE 78 North America CRO market size, by country, 2021 - 2027 (USD Mn)
  • TABLE 79 North America CRO market size, by service type, 2016 - 2020 (USD Mn)
  • TABLE 80 North America CRO market size, by service type, 2021 - 2027 (USD Mn)
  • TABLE 81 North America CRO market size, by early phase development services, 2016 - 2020 (USD Mn)
  • TABLE 82 North America CRO market size, by early phase development services, 2021 - 2027 (USD Mn)
  • TABLE 83 North America CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
  • TABLE 84 North America CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
  • TABLE 85 North America CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
  • TABLE 86 North America CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
  • TABLE 87 North America CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
  • TABLE 88 North America CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
  • TABLE 89 North America CRO market size, by analytical testing services, 2016 - 2020 (USD Mn)
  • TABLE 90 North America CRO market size, by analytical testing services, 2021 - 2027 (USD Mn)
  • TABLE 91 North America CRO market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 92 North America CRO market size, by therapeutic area, 2021 - 2027 (USD Mn)
  • TABLE 93 North America CRO market size, by end-use, 2016 - 2020 (USD Mn)
  • TABLE 94 North America CRO market size, by end-use, 2021 - 2027 (USD Mn)
  • TABLE 95 U.S. CRO market size, by service type, 2016 - 2020 (USD Mn)
  • TABLE 96 U.S. CRO market size, by service type, 2021 - 2027 (USD Mn)
  • TABLE 97 U.S. CRO market size, by early phase development services, 2016 - 2020 (USD Mn)
  • TABLE 98 U.S. CRO market size, by early phase development services, 2021 - 2027 (USD Mn)
  • TABLE 99 U.S. CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
  • TABLE 100 U.S. CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
  • TABLE 101 U.S. CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
  • TABLE 102 U.S. CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
  • TABLE 103 U.S. CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
  • TABLE 104 U.S. CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
  • TABLE 105 U.S. CRO market size, by analytical testing services, 2016 - 2020 (USD Mn)
  • TABLE 106 U.S. CRO market size, by analytical testing services, 2021 - 2027 (USD Mn)
  • TABLE 107 U.S. CRO market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 108 U.S. CRO market size, by therapeutic area, 2021 - 2027 (USD Mn)
  • TABLE 109 U.S. CRO market size, by end-use, 2016 - 2020 (USD Mn)
  • TABLE 110 U.S. CRO market size, by end-use, 2021 - 2027 (USD Mn)
  • TABLE 111 Canada CRO market size, by service type, 2016 - 2020 (USD Mn)
  • TABLE 112 Canada CRO market size, by service type, 2021 - 2027 (USD Mn)
  • TABLE 113 Canada CRO market size, by early phase development services, 2016 - 2020 (USD Mn)
  • TABLE 114 Canada CRO market size, by early phase development services, 2021 - 2027 (USD Mn)
  • TABLE 115 Canada CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
  • TABLE 116 Canada CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
  • TABLE 117 Canada CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
  • TABLE 118 Canada CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
  • TABLE 119 Canada CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
  • TABLE 120 Canada CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
  • TABLE 121 Canada CRO market size, by analytical testing services, 2016 - 2020 (USD Mn)
  • TABLE 122 Canada CRO market size, by analytical testing services, 2021 - 2027 (USD Mn)
  • TABLE 123 Canada CRO market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 124 Canada CRO market size, by therapeutic area, 2021 - 2027 (USD Mn)
  • TABLE 125 Canada CRO market size, by end-use, 2016 - 2020 (USD Mn)
  • TABLE 126 Canada CRO market size, by end-use, 2021 - 2027 (USD Mn)
  • TABLE 127 Europe CRO market size, by country, 2016 - 2020 (USD Mn)
  • TABLE 128 Europe CRO market size, by country, 2021 - 2027 (USD Mn)
  • TABLE 129 Europe CRO market size, by service type, 2016 - 2020 (USD Mn)
  • TABLE 130 Europe CRO market size, by service type, 2021 - 2027 (USD Mn)
  • TABLE 131 Europe CRO market size, by early phase development services, 2016 - 2020 (USD Mn)
  • TABLE 132 Europe CRO market size, by early phase development services, 2021 - 2027 (USD Mn)
  • TABLE 133 Europe CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
  • TABLE 134 Europe CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
  • TABLE 135 Europe CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
  • TABLE 136 Europe CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
  • TABLE 137 Europe CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
  • TABLE 138 Europe CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
  • TABLE 139 Europe CRO market size, by analytical testing services, 2016 - 2020 (USD Mn)
  • TABLE 140 Europe CRO market size, by analytical testing services, 2021 - 2027 (USD Mn)
  • TABLE 141 Europe CRO market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 142 Europe CRO market size, by therapeutic area, 2021 - 2027 (USD Mn)
  • TABLE 143 Europe CRO market size, by end-use, 2016 - 2020 (USD Mn)
  • TABLE 144 Europe CRO market size, by end-use, 2021 - 2027 (USD Mn)
  • TABLE 145 Germany CRO market size, by service type, 2016 - 2020 (USD Mn)
  • TABLE 146 Germany CRO market size, by service type, 2021 - 2027 (USD Mn)
  • TABLE 147 Germany CRO market size, by early phase development services, 2016 - 2020 (USD Million)
  • TABLE 148 Germany CRO market size, by early phase development services, 2021 - 2027 (USD Million)
  • TABLE 149 Germany CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
  • TABLE 150 Germany CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
  • TABLE 151 Germany CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
  • TABLE 152 Germany CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
  • TABLE 153 Germany CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
  • TABLE 154 Germany CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
  • TABLE 155 Germany CRO market size, by analytical testing services, 2016 - 2020 (USD Mn)
  • TABLE 156 Germany CRO market size, by analytical testing services, 2021 - 2027 (USD Mn)
  • TABLE 157 Germany CRO market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 158 Germany CRO market size, by therapeutic area, 2021 - 2027 (USD Mn)
  • TABLE 159 Germany CRO market size, by end-use, 2016 - 2020 (USD Mn)
  • TABLE 160 Germany CRO market size, by end-use, 2021 - 2027 (USD Mn)
  • TABLE 161 France CRO market size, by service type, 2016 - 2020 (USD Mn)
  • TABLE 162 France CRO market size, by service type, 2021 - 2027 (USD Mn)
  • TABLE 163 France CRO market size, by early phase development services, 2016 - 2020 (USD Mn)
  • TABLE 164 France CRO market size, by early phase development services, 2021 - 2027 (USD Mn)
  • TABLE 165 France CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
  • TABLE 166 France CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
  • TABLE 167 France CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
  • TABLE 168 France CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
  • TABLE 169 France CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
  • TABLE 170 France CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
  • TABLE 171 France CRO market size, by analytical testing services, 2016 - 2020 (USD Mn)
  • TABLE 172 France CRO market size, by analytical testing services, 2021 - 2027 (USD Mn)
  • TABLE 173 France CRO market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 174 France CRO market size, by therapeutic area, 2021 - 2027 (USD Mn)
  • TABLE 175 France CRO market size, by end-use, 2016 - 2020 (USD Mn)
  • TABLE 176 France CRO market size, by end-use, 2021 - 2027 (USD Mn)
  • TABLE 177 UK CRO market size, by service type, 2016 - 2020 (USD Mn)
  • TABLE 178 UK CRO market size, by service type, 2021 - 2027 (USD Mn)
  • TABLE 179 UK CRO market size, by early phase development services, 2016 - 2020 (USD Mn)
  • TABLE 180 UK CRO market size, by early phase development services, 2021 - 2027 (USD Mn)
  • TABLE 181 UK CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
  • TABLE 182 UK CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
  • TABLE 183 UK CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
  • TABLE 184 UK CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
  • TABLE 185 UK CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
  • TABLE 186 UK CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
  • TABLE 187 UK CRO market size, by analytical testing services, 2016 - 2020 (USD Mn)
  • TABLE 188 UK CRO market size, by analytical testing services, 2021 - 2027 (USD Mn)
  • TABLE 189 UK CRO market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 190 UK CRO market size, by therapeutic area, 2021 - 2027 (USD Mn)
  • TABLE 191 UK CRO market size, by end-use, 2016 - 2020 (USD Mn)
  • TABLE 192 UK CRO market size, by end-use, 2021 - 2027 (USD Mn)
  • TABLE 193 Italy CRO market size, by service type, 2016 - 2020 (USD Mn)
  • TABLE 194 Italy CRO market size, by service type, 2021 - 2027 (USD Mn)
  • TABLE 195 Italy CRO market size, by early phase development services, 2016 - 2020 (USD Mn)
  • TABLE 196 Italy CRO market size, by early phase development services, 2021 - 2027 (USD Mn)
  • TABLE 197 Italy CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
  • TABLE 198 Italy CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
  • TABLE 199 Italy CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
  • TABLE 200 Italy CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
  • TABLE 201 Italy CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
  • TABLE 202 Italy CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
  • TABLE 203 Italy CRO market size, by analytical testing services, 2016 - 2020 (USD Mn)
  • TABLE 204 Italy CRO market size, by analytical testing services, 2021 - 2027 (USD Mn)
  • TABLE 205 Italy CRO market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 206 Italy CRO market size, by therapeutic area, 2021 - 2027 (USD Mn)
  • TABLE 207 Italy CRO market size, by end-use, 2016 - 2020 (USD Mn)
  • TABLE 208 Italy CRO market size, by end-use, 2021 - 2027 (USD Mn)
  • TABLE 209 Spain CRO market size, by service type, 2016 - 2020 (USD Mn)
  • TABLE 210 Spain CRO market size, by service type, 2021 - 2027 (USD Mn)
  • TABLE 211 Spain CRO market size, by early phase development services, 2016 - 2020 (USD Mn)
  • TABLE 212 Spain CRO market size, by early phase development services, 2021 - 2027 (USD Mn)
  • TABLE 213 Spain CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
  • TABLE 214 Spain CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
  • TABLE 215 Spain CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
  • TABLE 216 Spain CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
  • TABLE 217 Spain CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
  • TABLE 218 Spain CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
  • TABLE 219 Spain CRO market size, by analytical testing services, 2016 - 2020 (USD Mn)
  • TABLE 220 Spain CRO market size, by analytical testing services, 2021 - 2027 (USD Mn)
  • TABLE 221 Spain CRO market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 222 Spain CRO market size, by therapeutic area, 2021 - 2027 (USD Mn)
  • TABLE 223 Spain CRO market size, by end-use, 2016 - 2020 (USD Mn)
  • TABLE 224 Spain CRO market size, by end-use, 2021 - 2027 (USD Mn)
  • TABLE 225 Asia Pacific CRO market size, by country, 2016 - 2020 (USD Mn)
  • TABLE 226 Asia Pacific CRO market size, by country, 2021 - 2027 (USD Mn)
  • TABLE 227 Asia Pacific CRO market size, by service type, 2016 - 2020 (USD Mn)
  • TABLE 228 Asia Pacific CRO market size, by service type, 2021 - 2027 (USD Mn)
  • TABLE 229 Asia Pacific CRO market size, by early phase development services, 2016 - 2020 (USD Million)
  • TABLE 230 Asia Pacific CRO market size, by early phase development services, 2021 - 2027 (USD Million)
  • TABLE 231 Asia Pacific CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
  • TABLE 232 Asia Pacific CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
  • TABLE 233 Asia Pacific CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
  • TABLE 234 Asia Pacific CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
  • TABLE 235 Asia Pacific CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
  • TABLE 236 Asia Pacific CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
  • TABLE 237 Asia Pacific CRO market size, by analytical testing services, 2016 - 2020 (USD Mn)
  • TABLE 238 Asia Pacific CRO market size, by analytical testing services, 2021 - 2027 (USD Mn)
  • TABLE 239 Asia Pacific CRO market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 240 Asia Pacific CRO market size, by therapeutic area, 2021 - 2027 (USD Mn)
  • TABLE 241 Asia Pacific CRO market size, by end-use, 2016 - 2020 (USD Mn)
  • TABLE 242 Asia Pacific CRO market size, by end-use, 2021 - 2027 (USD Mn)
  • TABLE 243 Japan CRO market size, by service type, 2016 - 2020 (USD Mn)
  • TABLE 244 Japan CRO market size, by service type, 2021 - 2027 (USD Mn)
  • TABLE 245 Japan CRO market size, by early phase development services, 2016 - 2020 (USD Mn)
  • TABLE 246 Japan CRO market size, by early phase development services, 2021 - 2027 (USD Mn)
  • TABLE 247 Japan CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
  • TABLE 248 Japan CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
  • TABLE 249 Japan CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
  • TABLE 250 Japan CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
  • TABLE 251 Japan CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
  • TABLE 252 Japan CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
  • TABLE 253 Japan CRO market size, by analytical testing services, 2016 - 2020 (USD Mn)
  • TABLE 254 Japan CRO market size, by analytical testing services, 2021 - 2027 (USD Mn)
  • TABLE 255 Japan CRO market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 256 Japan CRO market size, by therapeutic area, 2021 - 2027 (USD Mn)
  • TABLE 257 Japan CRO market size, by end-use, 2016 - 2020 (USD Mn)
  • TABLE 258 Japan CRO market size, by end-use, 2021 - 2027 (USD Mn)
  • TABLE 259 India CRO market size, by service type, 2016 - 2020 (USD Mn)
  • TABLE 260 India CRO market size, by service type, 2021 - 2027 (USD Mn)
  • TABLE 261 India CRO market size, by early phase development services, 2016 - 2020 (USD Mn)
  • TABLE 262 India CRO market size, by early phase development services, 2021 - 2027 (USD Mn)
  • TABLE 263 India CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
  • TABLE 264 India CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
  • TABLE 265 India CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
  • TABLE 266 India CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
  • TABLE 267 India CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
  • TABLE 268 India CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
  • TABLE 269 India CRO market size, by analytical testing services, 2016 - 2020 (USD Mn)
  • TABLE 270 India CRO market size, by analytical testing services, 2021 - 2027 (USD Mn)
  • TABLE 271 India CRO market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 272 India CRO market size, by therapeutic area, 2021 - 2027 (USD Mn)
  • TABLE 273 India CRO market size, by end-use, 2016 - 2020 (USD Mn)
  • TABLE 274 India CRO market size, by end-use, 2021 - 2027 (USD Mn)
  • TABLE 275 China CRO market size, by service type, 2016 - 2020 (USD Mn)
  • TABLE 276 China CRO market size, by service type, 2021 - 2027 (USD Mn)
  • TABLE 277 China CRO market size, by early phase development services, 2016 - 2020 (USD Mn)
  • TABLE 278 China CRO market size, by early phase development services, 2021 - 2027 (USD Mn)
  • TABLE 279 China CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
  • TABLE 280 China CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
  • TABLE 281 China CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
  • TABLE 282 China CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
  • TABLE 283 China CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
  • TABLE 284 China CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
  • TABLE 285 China CRO market size, by analytical testing services, 2016 - 2020 (USD Mn)
  • TABLE 286 China CRO market size, by analytical testing services, 2021 - 2027 (USD Mn)
  • TABLE 287 China CRO market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 288 China CRO market size, by therapeutic area, 2021 - 2027 (USD Mn)
  • TABLE 289 China CRO market size, by end-use, 2016 - 2020 (USD Mn)
  • TABLE 290 China CRO market size, by end-use, 2021 - 2027 (USD Mn)
  • TABLE 291 Latin America CRO market size, by country, 2016 - 2020 (USD Mn)
  • TABLE 292 Latin America CRO market size, by country, 2021 - 2027 (USD Mn)
  • TABLE 293 Latin America CRO market size, by service type, 2016 - 2020 (USD Mn)
  • TABLE 294 Latin America CRO market size, by service type, 2021 - 2027 (USD Mn)
  • TABLE 295 Latin America CRO market size, by early phase development services, 2016 - 2020 (USD Million)
  • TABLE 296 Latin America CRO market size, by early phase development services, 2021 - 2027 (USD Million)
  • TABLE 297 Latin America CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
  • TABLE 298 Latin America CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
  • TABLE 299 Latin America CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
  • TABLE 300 Latin America CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
  • TABLE 301 Latin America CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
  • TABLE 302 Latin America CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
  • TABLE 303 Latin America CRO market size, by analytical testing services, 2016 - 2020 (USD Mn)
  • TABLE 304 Latin America CRO market size, by analytical testing services, 2021 - 2027 (USD Mn)
  • TABLE 305 Latin America CRO market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 306 Latin America CRO market size, by therapeutic area, 2021 - 2027 (USD Mn)
  • TABLE 307 Latin America CRO market size, by end-use, 2016 - 2020 (USD Mn)
  • TABLE 308 Latin America CRO market size, by end-use, 2021 - 2027 (USD Mn)
  • TABLE 309 Brazil CRO market size, by service type, 2016 - 2020 (USD Mn)
  • TABLE 310 Brazil CRO market size, by service type, 2021 - 2027 (USD Mn)
  • TABLE 311 Brazil CRO market size, by early phase development services, 2016 - 2020 (USD Mn)
  • TABLE 312 Brazil CRO market size, by early phase development services, 2021 - 2027 (USD Mn)
  • TABLE 313 Brazil CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
  • TABLE 314 Brazil CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
  • TABLE 315 Brazil CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
  • TABLE 316 Brazil CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
  • TABLE 317 Brazil CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
  • TABLE 318 Brazil CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
  • TABLE 319 Brazil CRO market size, by analytical testing services, 2016 - 2020 (USD Mn)
  • TABLE 320 Brazil CRO market size, by analytical testing services, 2021 - 2027 (USD Mn)
  • TABLE 321 Brazil CRO market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 322 Brazil CRO market size, by therapeutic area, 2021 - 2027 (USD Mn)
  • TABLE 323 Brazil CRO market size, by end-use, 2016 - 2020 (USD Mn)
  • TABLE 324 Brazil CRO market size, by end-use, 2021 - 2027 (USD Mn)
  • TABLE 325 Mexico CRO market size, by service type, 2016 - 2020 (USD Mn)
  • TABLE 326 Mexico CRO market size, by service type, 2021 - 2027 (USD Mn)
  • TABLE 327 Mexico CRO market size, by early phase development services, 2016 - 2020 (USD Mn)
  • TABLE 328 Mexico CRO market size, by early phase development services, 2021 - 2027 (USD Mn)
  • TABLE 329 Mexico CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
  • TABLE 330 Mexico CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
  • TABLE 331 Mexico CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
  • TABLE 332 Mexico CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
  • TABLE 333 Mexico CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
  • TABLE 334 Mexico CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
  • TABLE 335 Mexico CRO market size, by analytical testing services, 2016 - 2020 (USD Mn)
  • TABLE 336 Mexico CRO market size, by analytical testing services, 2021 - 2027 (USD Mn)
  • TABLE 337 Mexico CRO market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 338 Mexico CRO market size, by therapeutic area, 2021 - 2027 (USD Mn)
  • TABLE 339 Mexico CRO market size, by end-use, 2016 - 2020 (USD Mn)
  • TABLE 340 Mexico CRO market size, by end-use, 2021 - 2027 (USD Mn)
  • TABLE 341 MEA CRO market size, by country, 2016 - 2020 (USD Mn)
  • TABLE 342 MEA CRO market size, by country, 2021 - 2027 (USD Mn)
  • TABLE 343 MEA CRO market size, by service type, 2016 - 2020 (USD Mn)
  • TABLE 344 MEA CRO market size, by service type, 2021 - 2027 (USD Mn)
  • TABLE 345 MEA CRO market size, by early phase development services, 2016 - 2020 (USD Mn)
  • TABLE 346 MEA CRO market size, by early phase development services, 2021 - 2027 (USD Mn)
  • TABLE 347 MEA CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
  • TABLE 348 MEA CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
  • TABLE 349 MEA CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
  • TABLE 350 MEA CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
  • TABLE 351 MEA CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
  • TABLE 352 MEA CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
  • TABLE 353 MEA CRO market size, by analytical testing services, 2016 - 2020 (USD Mn)
  • TABLE 354 MEA CRO market size, by analytical testing services, 2021 - 2027 (USD Mn)
  • TABLE 355 MEA CRO market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 356 MEA CRO market size, by therapeutic area, 2021 - 2027 (USD Mn)
  • TABLE 357 MEA CRO market size, by end-use, 2016 - 2020 (USD Mn)
  • TABLE 358 MEA CRO market size, by end-use, 2021 - 2027 (USD Mn)
  • TABLE 359 Saudi Arabia CRO market size, by service type, 2016 - 2020 (USD Mn)
  • TABLE 360 Saudi Arabia CRO market size, by service type, 2021 - 2027 (USD Mn)
  • TABLE 361 Saudi Arabia CRO market size, by early phase development services, 2016 - 2020 (USD Million)
  • TABLE 362 Saudi Arabia CRO market size, by early phase development services, 2021 - 2027 (USD Million)
  • TABLE 363 Saudi Arabia CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
  • TABLE 364 Saudi Arabia CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
  • TABLE 365 Saudi Arabia CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
  • TABLE 366 Saudi Arabia CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
  • TABLE 367 Saudi Arabia CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
  • TABLE 368 Saudi Arabia CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
  • TABLE 369 Saudi Arabia CRO market size, by analytical testing services, 2016 - 2020 (USD Mn)
  • TABLE 370 Saudi Arabia CRO market size, by analytical testing services, 2021 - 2027 (USD Mn)
  • TABLE 371 Saudi Arabia CRO market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 372 Saudi Arabia CRO market size, by therapeutic area, 2021 - 2027 (USD Mn)
  • TABLE 373 Saudi Arabia CRO market size, by end-use, 2016 - 2020 (USD Mn)
  • TABLE 374 Saudi Arabia CRO market size, by end-use, 2021 - 2027 (USD Mn)
  • TABLE 375 South Africa CRO market size, by service type, 2016 - 2020 (USD Mn)
  • TABLE 376 South Africa CRO market size, by service type, 2021 - 2027 (USD Mn)
  • TABLE 377 South Africa CRO market size, by early phase development services, 2016 - 2020 (USD Million)
  • TABLE 378 South Africa CRO market size, by early phase development services, 2021 - 2027 (USD Million)
  • TABLE 379 South Africa CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
  • TABLE 380 South Africa CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
  • TABLE 381 South Africa CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
  • TABLE 382 South Africa CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
  • TABLE 383 South Africa CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
  • TABLE 384 South Africa CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
  • TABLE 385 South Africa CRO market size, by analytical testing services, 2016 - 2020 (USD Mn)
  • TABLE 386 South Africa CRO market size, by analytical testing services, 2021 - 2027 (USD Mn)
  • TABLE 387 South Africa CRO market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 388 South Africa CRO market size, by therapeutic area, 2021 - 2027 (USD Mn)
  • TABLE 389 South Africa CRO market size, by end-use, 2016 - 2020 (USD Mn)
  • TABLE 390 South Africa CRO market size, by end-use, 2021 - 2027 (USD Mn)

Charts & Figures

  • FIG. 1 Top-down approach
  • FIG. 2 Breakdown of primary participants
  • FIG. 3 Contract research organization industry 360 degree synopsis, 2016-2027
  • FIG. 4 Industry segmentation
  • FIG. 5 Growth potential analysis, by service type
  • FIG. 6 Growth potential analysis, by therapeutic area
  • FIG. 7 Growth potential analysis, by end-use
  • FIG. 8 Porter's analysis
  • FIG. 9 Company matrix analysis, 2020
  • FIG. 10 PESTEL analysis
  • FIG. 11 Key segment trends, by service type
  • FIG. 12 Key segment trends, by therapeutic area
  • FIG. 13 Key segment trends, by end-use
  • FIG. 14 Key regional trends
  • FIG. 15 Competitive dashboard, 2020